BillionToOne, Inc (NASDAQ:BLLN) IPO will take place November, 06 on the NASDAQ exchange under the ticker BLLN.

The company is offering shares at an expected price between $49.00 and $55.00 per share with an insider lock-up period of 180 days ending on May 05, 2026.

See also: Benzinga IPO Calendar

About BillionToOne, Inc

BillionToOne is transforming healthcare by redefining molecular diagnostics. Our revolutionary single molecule NGS (smNGS) platform achieves what was once thought impossible – detecting and precisely quantifying genetic targets with single-molecule sensitivity. At the heart of this technological breakthrough lies our patented QCTs, enabling measurements at the physical limit of detection – the single DNA molecule. This leap forward addresses a fundamental limitation in healthcare – the inability to detect sparse but clinically crucial disease signals in cfDNA.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.